From leveraging existing resources to filling gaps with innovative tools, partnerships throughout the healthcare industry can help meet the needs of more patients and drive impact in an accelerated way.

In this episode, Eric Racine is joined by Vicky DiBiaso, Global Head of Patient Informed Development and Health Value Translation at Sanofi, and Sara Loud from the Accelerated Cure Project, to discuss the transformative efforts of the Patient Advocacy Leaders in Drug Development Industry Network, also known as Paladin. Paladin is driving collaboration across biopharmaceutical companies and patient advocacy groups to help advance the development of life-saving treatments. They examine the challenges and opportunities in transforming healthcare innovation, with an emphasis on speed, inclusivity and collaboration.

David Panzirer, a trustee of the Helmsley Charitable Trust, discovered his calling when his daughter was diagnosed with type 1 diabetes (T1D). A businessperson at his core, David views healthcare grants as investments, and his team continuously develops a deep understanding of the ecosystem as a key success factor to maximize their impact. Learn from one of the most significant players in the field of venture philanthropy, his team’s portfolio approach to healthcare investments, and their singular focus to improve people’s lives living with disease. Sanofi host Eric Racine and co-host Andrew Vilcinskas – a T1D patient himself – discuss with David the intersection of advocacy, philanthropy and business.

The Leona M. and Harry B. Helmsley Charitable Trust is a global philanthropy committed to helping people live better lives today and creating stronger, healthier futures for individuals and communities. They partner with people and organizations to invest in new ideas or research across six program areas. The Type 1 Diabetes (T1D) program is dedicated to helping the global T1D community live safer, better, and more fulfilling lives today while funding advancements in research and technology for a better tomorrow.

To help make an impact for patients, it's important to have a comprehensive understanding of how a disease impacts their day-to-day lives. Michael Osso, Chief Executive Officer of the Crohn's & Colitis Foundation knows this well. He and his team created a comprehensive research ecosystem that harnesses data– from reported anecdotes to clinical data, biosamples and more – to help researchers, patients, advocates and care teams get a holistic view of inflammatory bowel diseases (IBD) and drive advancements in the space.

Sanofi host, Eric Racine and co-host Michael George discuss with him the importance of taking on such a large-scale project – one step at a time – and the dedication to building patient level data to inspire and accelerate research innovations for patients with IBD.